TCL Archive NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention. March 2, 2007
TCL Archive NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period October 18, 1985
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002